Ingersoll Rand Acquires Scinomix to Expand Life Sciences Portfolio
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Source: Globenewswire
- Strategic Acquisition: Ingersoll Rand's acquisition of Scinomix at an attractive pre-synergy purchase multiple of approximately 10x 2025 Adjusted EBITDA significantly enhances its competitive position in the life sciences sector.
- Technology Integration: This acquisition enables the combination of Scinomix's automation technologies with Ingersoll Rand's existing solutions, allowing the company to provide comprehensive end-to-end laboratory solutions that enhance workflow efficiency and accuracy for customers.
- Market Expansion: The addition of Scinomix not only enriches Ingersoll Rand's product portfolio but also opens new opportunities for market expansion across various industries, including clinical, pharmaceutical, and biotechnology, further solidifying its leadership in the life sciences field.
- Innovation-Driven: CEO Vicente Reynal stated that this acquisition will drive the expansion of innovative solutions, helping to better serve customers and increase market share, reflecting the company's long-term commitment to the life sciences sector.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on IR
Wall Street analysts forecast IR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IR is 90.50 USD with a low forecast of 81.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 85.250
Low
81.00
Averages
90.50
High
100.00
Current: 85.250
Low
81.00
Averages
90.50
High
100.00
About IR
Ingersoll Rand Inc. is a provider of mission-critical flow creation and life sciences and industrial solutions. Its Industrial Technologies and Services segment designs, manufactures, markets and services a range of compression and vacuum equipment as well as fluid transfer equipment, and loading systems. Its compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, clean energy, environmental and other applications. The Precision and Science Technologies segment, designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment, single-use powder handling systems, and contract design and production services for silicone, thermoplastic, and specialty components and assemblies for medical devices. It also designs and manufactures plastic product solutions for life science and healthcare technology industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ingersoll Rand and Others Face Severe EPS Downgrades Ahead of Earnings Season
- Earnings Downgrades: Ingersoll Rand Inc. (IR) faces the steepest earnings downgrades with an EPS revision grade of F and a Quant rating of 2.04, indicating strong analyst concerns about its near-term performance, which may lead to decreased investor confidence.
- Industry Pressure: Kuehne + Nagel International AG (KHNGY) also suffers from an F EPS revision grade and a Quant rating of 2.67, suggesting doubts about its competitiveness in the global logistics sector, potentially affecting its future market share.
- Multiple Companies Challenged: Owens Corning (OC) and Komatsu Ltd. (KMTUY) are rated F with Quant ratings of 1.76 and 2.02 respectively, highlighting significant challenges in profitability and market performance, which could lead to stock price volatility.
- Analyst Skepticism: Overall, among 20 large-cap industrial companies, the majority have EPS revision grades of D- or F, reflecting a pessimistic outlook from analysts regarding their earnings capabilities, which may influence investor decisions and market sentiment.
Continue Reading
Ingersoll Rand (IR) Schedules Q4 2025 Earnings Release and Conference Call
- Earnings Release Schedule: Ingersoll Rand is set to release its Q4 2025 earnings after market close on February 12, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will host a conference call on February 13, 2026, at 8 a.m. Eastern Time to discuss the earnings results, aiming to enhance interaction and information sharing with investors.
- Participation Details: Investors can join the call by dialing +1-888-330-3073 domestically or +1-646-960-0683 internationally, using access code 8970061, ensuring broad dissemination of information.
- Webcast Replay Availability: A replay of the webcast will be accessible on Ingersoll Rand's Investor Relations website after the conference, further improving the accessibility and transparency of company information.
Continue Reading